A few weeks ago, the FDA approved a costly Alzheimer’s drug developed by Biogen, but for what benefit?1. There is not strong evidence that Amyloid beta plaques causes Alzheimer’s disease, even if aducanumab showed a reduction in those plaques.2. Aducan…